MedPath

Use of ultrasonography for avoiding hypotension due to spinal anesthesia

Active, not recruiting
Conditions
Other specified joint disorders,
Registration Number
CTRI/2020/10/028612
Lead Sponsor
S N Medical College and HSK Hospital
Brief Summary

Spinal anaesthesia isfrequently used in daily clinical practice. Post spinal anaesthesia  hypotension (PSAH) is a common side effectwith an incidence of 15.3% to 33% that may result in organ hypoperfusion andischaemic events1,2.The two fundamental factors in the pathogenesisof PSAH are sensory block level at or above T5 and age more than 40 years3.Patients’susceptibility to intra-operative hypotension can also be influenced by thepre-operative volume status that may differ according to comorbidities,physical status, pre-operative medications and fasting4.

PSAHdue to spinal blockade is principally a consequence of diminished systemicvascular resistance after blockade of preganglionic sympathetic fibers. Manyattempts have been tried to prevent PSAH, such as intravenous  volume preload  or  prophylactic vasopressors. However,fluid co-load has been proved to lower the incidence of PSAH and significantlydecrease the vasopressor requirements. At the same time, empirical volumeloading carries the potential of volume overload, particularly in patients withcardiac disease. Consequently, the search for predictors of PSAH isbecoming mandatory to avoid blind volume loading and reserve it only forpatients who are expected to develop PSAH.

Severalmethodologies have been tried with a specific goal to predict PSAH, includingheart rate variability (HRV), passive leg raise test and perfusion index5,6,7.Althoughsome studies found a positive predictive value of HRV with high sensitivity andspecificity for PSAH, others concluded that it was not a reliable predictor asit can be influenced by numerous factors such as diabetes mellitus, ischaemicheart disease, antihypertensive medications, anxiety and spontaneousrespiration5.

Variousparameters have been investigated recently to estimate the pre-operativeintravascular volume status. Sonographic determination of inferior vena cavacollapsibility index (IVCCI) and IVC to aorta diameter index (IVC : Ao index) hasbeen introduced into clinical practice for the assessment of intravascularvolume in many studies and reported to be easy reliable and noninvasive  for evaluating the volume status. So, the aimof this study is to evaluate the efficacy of both pre-operative IVCCI and IVC :Ao index for predicting the occurrence of PSAH.

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
All
Target Recruitment
120
Inclusion Criteria
  • ASA physical status I to II.
  • Age between 18 to 60 years.
  • Patientss undergoing elective surgeries under spinal anaesthesia.
Exclusion Criteria
  • Absolute or relative contraindications to spinal anaesthesia 2.
  • Patients on angiotensin converting enzyme inhibitors, 3.
  • Pregnant women 4.
  • Emergency cases 5.
  • BMI more than 30 kg m−2 6.
  • Failure to perform spinal anaesthesia.
  • Patients with a baseline arterial SBP less than 90 mmHg or mean arterial blood pressure (MBP) less than 70 mmHg.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Based on our study, patients prone for spinal hypotension can be identified before anesthesia and can be treated effectively with crystalloids without causing fluid overload and thereby prevent spinal anesthesia induced hypotension and also reduce the requirement of vasoactive agents.Before starting surgery, at the end of the surgery
Secondary Outcome Measures
NameTimeMethod
•Perioperative fluid requirement•Requirement of vasopressors

Trial Locations

Locations (1)

HSK HOSPITAL ,S N Medical College

🇮🇳

Bagalkot, KARNATAKA, India

HSK HOSPITAL ,S N Medical College
🇮🇳Bagalkot, KARNATAKA, India
Dr Manjunath B
Principal investigator
09480013943
manjunath0993@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.